BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 30981841)

  • 21. The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer.
    Elsharawy KA; Mohammed OJ; Aleskandarany MA; Hyder A; El-Gammal HL; Abou-Dobara MI; Green AR; Dalton LW; Rakha EA
    Br J Cancer; 2020 Nov; 123(10):1543-1552. PubMed ID: 32868896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment.
    Murphy JM; Rodriguez YAR; Jeong K; Ahn EE; Lim SS
    Exp Mol Med; 2020 Jun; 52(6):877-886. PubMed ID: 32514188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
    Bennett L; Mallon EA; Horgan PG; Paul A; McMillan DC; Edwards J
    Oncotarget; 2017 May; 8(20):33002-33013. PubMed ID: 28423692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.
    Cheng KK; Dickson A; Gujam FJ; McMillan DC; Edwards J
    Histopathology; 2017 Apr; 70(5):782-797. PubMed ID: 27891654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between total and phosphorylated STAT1 and STAT3 tumour cell expression, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
    Gujam FJ; McMillan DC; Edwards J
    Oncotarget; 2016 Nov; 7(47):77607-77621. PubMed ID: 27769057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.
    Gujam FJ; Edwards J; Mohammed ZM; Going JJ; McMillan DC
    Br J Cancer; 2014 Jul; 111(1):157-65. PubMed ID: 24874480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
    Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
    JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer.
    Andisha NM; McMillan DC; Gujam FJA; Roseweir A; Edwards J
    Cell Signal; 2019 Aug; 60():91-99. PubMed ID: 30981841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune microenvironment in different molecular subtypes of ductal breast carcinoma.
    Sadeghalvad M; Mohammadi-Motlagh HR; Rezaei N
    Breast Cancer Res Treat; 2021 Jan; 185(2):261-279. PubMed ID: 33011829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAK in cancer: mechanistic findings and clinical applications.
    Sulzmaier FJ; Jean C; Schlaepfer DD
    Nat Rev Cancer; 2014 Sep; 14(9):598-610. PubMed ID: 25098269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Wang W; Liu H; Guo W; Li P; Deng M
    Transl Oncol; 2020 Nov; 13(11):100835. PubMed ID: 32702646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression.
    Rigiracciolo DC; Cirillo F; Talia M; Muglia L; Gutkind JS; Maggiolini M; Lappano R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562737
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.